Antileishmanial activity of lapachol analogues
AUTOR(ES)
Lima, Nadja MF, Correia, Clariane S, Leon, Leonor L, Machado, Gérzia MC, Madeira, Maria de Fátima, Santana, Antônio Euzébio G, Goulart, Marília OF
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2004-11
RESUMO
The antileishmanial activity of lapachol, isolapachol, and dihydrolapachol, along with soluble derivatives (potassium salt) and acetate was obtained. All the compounds were assayed against metacyclic promastigotes of two different species of Leishmania associated to tegumentar leishmaniasis: L. amazonensis and L. braziliensis. All compounds presented significant activity, being isolapachol acetate the most active against promastigotes, with IC50/24h = 1.6 ± 0.0 µg/ml and 3.4 ± 0.5 µg/ml for, respectively, L. amazonensis and L. braziliensis. This compound was also assayed in vivo against L. amazonensis and showed to be active. Its toxicity in vitro was also established, and at concentration similar to the IC50, no toxicity was evidenced. In all experiments, pentamidine isethionate was used as a reference drug. The present results reinforce the potential use of substituted hydroxyquinones and derivatives as promising antileishmanial drugs and suggest a continuing study within this class of compounds.
Documentos Relacionados
- Suzuki-Miyaura Coupling between 3-Iodolawsone and Arylboronic Acids. Synthesis of Lapachol Analogues with Antineoplastic and Antileishmanial Activities
- Antileishmanial activity of chlorpromazine.
- Synthesis, X-ray crystal structure and theoretical calculations of antileishmanial neolignan analogues
- N-Myristoyltransferases as antileishmanial targets: a piggyback approach with benzoheterocyclic analogues
- New enamine derivatives of lapachol and biological activity